Genetic and Behavioral Analyses of the dFMR1 Pathway in Drosophila Peripheral Nervous System

Genetic and Behavioral Analyses of the dFMR1 Pathway in Drosophila Peripheral Nervous System

With a $160,000 grant from FRAXA Research Foundation from 2004-2006, Dr. Fen-Biao Gao and his team at the University of California studied the relationship between mRNA and FMRP.

Read more

Transcriptional Regulation of the Fragile X Gene

Transcriptional Regulation of the Fragile X Gene

With a $95,000 grant from FRAXA Research Foundation from 2001-2006, Dr. Justin Fallon and his team at Brown University studied systematic mapping of Fragile X granules in developing mouse brains, revealing a potential role for presynaptic FMRP in sensorimotor functions.

Read more

Alterations in Neocortical Neuron Excitability Associated with Fragile X

Alterations in Neocortical Neuron Excitability Associated with Fragile X

With a $107,000 grant from FRAXA Research Foundation from 2005-2006, Dr. Charles Cox at the University of Illinois looked for alterations in the intrinsic excitability of individual neurons within the visual neocortex in Fragile X syndrome.

Read more

Pharmacologic Interventions in the Fmr1 KO Mouse

Pharmacologic Interventions in the Fmr1 KO Mouse

With $48,600 in grants from FRAXA Research Foundation over 2004-2006, Dr. Catherine Choi at Drexel University studied Fragile X knockout mice to determine future treatment targets for Fragile X syndrome in humans.

Read more

FMR Expression in Zebra Finch

FMR Expression in Zebra Finch

With a $18,500 grant from FRAXA Research Foundation in 2006, Dr. Stephanie Ceman fromthe University of Illinois studied Fragile X in zebra finches to better understand the impairments of verbal expression in individuals with Fragile X syndrome. Results published.

Read more

Transgenic Mouse Models of Fragile X Syndrome

Transgenic Mouse Models of Fragile X Syndrome

With $736,000 in grants from FRAXA Research Foundation over 2000-2007, Dr. Robert Bauchwitz at Columbia University developed 15 transgenic mouse models of Fragile X syndrome, using them to evaluate a range of experimental treatments. Results published.

Read more